Equity-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2022

Equity-Based Compensation

Summary of the restricted stock

		WEIGHTED-
		AVERAGE
		GRANT DATE
	SHARES	FAIR VALUE
Non-vested restricted stock as of December 31, 2021	3,910,722	$	23.18
Granted	—		—
Vested	(582,762)		23.19
Forfeited	—		—
Non-vested restricted stock as of June 30, 2022	3,327,960	$	23.18

Summary of the Company's RSU activity

		WEIGHTED-
		AVERAGE
		GRANT DATE
	UNITS	FAIR VALUE
Non-vested RSUs as of December 31, 2021	1,288,724	$	29.28
Granted*	1,375,817		22.09
Vested**	(326,077)		27.34
Forfeited	(45,197)		24.83
Non-vested RSUs as of June 30, 2022	2,293,267	$	25.33

Schedule of nonvested Performance-based Units activity

		WEIGHTED-
		AVERAGE
		GRANT DATE
	UNITS	FAIR VALUE
Non-vested PSUs as of December 31, 2021	406,575	$	27.35
Granted	361,147		22.25
Vested	(12,291)		24.83
Forfeited	—		—
Non-vested PSUs as of June 30, 2022	755,431	$	24.95

Schedule of compensation expense

	THREE MONTHS ENDED JUNE 30,				SIX MONTHS ENDED JUNE 30,
	2022		2021		2022		2021
Cost of revenues	$	2,657	$	1,456	$	4,380	$	2,296
Sales and marketing		850		636		1,510		1,034
Research and development		1,785		615		3,158		1,014
General and administrative		4,209		4,823		7,966		8,337
Total	$	9,501	$	7,530	$	17,014	$	12,681